MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 228 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,200 | -18.4% | 31,920 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $391,098 | -13.8% | 31,464 | -2.9% | 0.00% | -25.0% |
| Q1 2023 | $453,882 | +0.5% | 32,397 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $451,466 | -41.8% | 31,549 | +3.8% | 0.00% | -50.0% |
| Q3 2022 | $776,000 | -9.8% | 30,384 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $860,000 | -19.2% | 30,282 | +0.3% | 0.01% | -11.1% |
| Q1 2022 | $1,065,000 | -15.5% | 30,205 | +0.5% | 0.01% | -10.0% |
| Q4 2021 | $1,260,000 | -15.6% | 30,066 | -1.1% | 0.01% | -16.7% |
| Q3 2021 | $1,493,000 | +46.9% | 30,413 | +24.9% | 0.01% | +50.0% |
| Q2 2021 | $1,016,000 | – | 24,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |